Autoimmune Diseases

Table of Contents: 2012

  • Autoimmune Diseases -
  • Special Issue
  • Volume 2012
  • - Article ID 160830
  • - Review Article

Theranostic Implications of Nanotechnology in Multiple Sclerosis: A Future Perspective

Ajay Vikram Singh | Manish Khare | ... | Paolo Zamboni
  • Autoimmune Diseases -
  • Special Issue
  • Volume 2012
  • - Article ID 957802
  • - Research Article

Inflammatory Demyelinating Central Nervous System Diseases in Childhood: Clinical and Paraclinical Profiles in 133 Patients

Derya Kaya | Egemen İdiman | Serkan Özakbaş
  • Autoimmune Diseases -
  • Special Issue
  • Volume 2012
  • - Article ID 296214
  • - Research Article

Autoantibodies in Senear-Usher Syndrome: Cross-Reactivity or Multiple Autoimmunity?

María Elena Pérez-Pérez | Esperanza Avalos-Díaz | Rafael Herrera-Esparza
  • Autoimmune Diseases -
  • Special Issue
  • - Volume 2012
  • - Article ID 617213
  • - Review Article

The Immunosuppressive Activity of Heat Shock Protein 70

Pawel Stocki | Anne M. Dickinson
  • Autoimmune Diseases -
  • Special Issue
  • Volume 2012
  • - Article ID 357101
  • - Review Article

Anti-Integrin Therapy for Multiple Sclerosis

Eiji Kawamoto | Susumu Nakahashi | ... | Motomu Shimaoka
  • Autoimmune Diseases -
  • Special Issue
  • - Volume 2012
  • - Article ID 836519
  • - Review Article

Impact of Exercise and Metabolic Disorders on Heat Shock Proteins and Vascular Inflammation

Earl G. Noble | Garry X. Shen
  • Autoimmune Diseases -
  • Special Issue
  • Volume 2012
  • - Article ID 312817
  • - Review Article

Autoimmune Hepatitis as a Unique Form of an Autoimmune Liver Disease: Immunological Aspects and Clinical Overview

Hind I. Fallatah | Hisham O. Akbar
  • Autoimmune Diseases -
  • Special Issue
  • - Volume 2012
  • - Article ID 502813
  • - Review Article

Heat Shock Proteins: Pathogenic Role in Atherosclerosis and Potential Therapeutic Implications

Arman Kilic | Kaushik Mandal
  • Autoimmune Diseases -
  • Special Issue
  • Volume 2012
  • - Article ID 841085
  • - Research Article

Use of Complementary and Alternative Medicine among People with Multiple Sclerosis in the Nordic Countries

L. Skovgaard | P. H. Nicolajsen | ... | D. W. Meyrowitsch
  • Autoimmune Diseases -
  • Special Issue
  • - Volume 2012
  • - Article ID 683212
  • - Editorial

Neurologic Manifestations of Autoimmune Diseases

Simone Appenzeller | Yehuda Shoenfeld | Jozélio Freire de Carvalho
  • Autoimmune Diseases -
  • Special Issue
  • Volume 2012
  • - Article ID 565039
  • - Clinical Study

Multicenter Retrospective Analysis of the Effectiveness and Safety of Rituximab in Korean Patients with Refractory Systemic Lupus Erythematosus

So-Young Bang | Chang Keun Lee | ... | Hye-Soon Lee
  • Autoimmune Diseases -
  • Special Issue
  • Volume 2012
  • - Article ID 784364
  • - Review Article

Cost-Effectiveness of Multiple Sclerosis Disease-Modifying Therapies: A Systematic Review of the Literature

David Yamamoto | Jonathan D. Campbell
  • Autoimmune Diseases -
  • Special Issue
  • - Volume 2012
  • - Article ID 815753
  • - Editorial

Systemic Lupus Erythematosus

Hiroshi Okamoto | Ricard Cervera | ... | Taku Yoshio
  • Autoimmune Diseases -
  • Special Issue
  • - Volume 2012
  • - Article ID 814048
  • - Research Article

A Novel Method for Real-Time, Continuous, Fluorescence-Based Analysis of Anti-DNA Abzyme Activity in Systemic Lupus

Michelle F. Cavallo | Anna M. Kats | ... | Mirjana Pavlovic
  • Autoimmune Diseases -
  • Special Issue
  • Volume 2012
  • - Article ID 403915
  • - Research Article

A Comparison of Epitope Repertoires Associated with Myasthenia Gravis in Humans and Nonhuman Hosts

Kerrie Vaughan | Yohan Kim | Alessandro Sette
Autoimmune Diseases
 Journal metrics
See full report
Acceptance rate-
Submission to final decision-
Acceptance to publication-
CiteScore4.600
Journal Citation Indicator0.400
Impact Factor4.0
 Submit Check your manuscript for errors before submitting

We have begun to integrate the 200+ Hindawi journals into Wiley’s journal portfolio. You can find out more about how this benefits our journal communities on our FAQ.